News

Published on 16 May 2023 on Market Watch

U.S. stocks will soon be reshuffled in the Russell reconstitution. Here’s how Goldman Sachs sees the...


Article preview image

Stock-market investors are soon facing a reconstitution of U.S. Russell indexes, an annual process resulting in the deletion and addition of companies in widely-followed benchmarks.

Almost $4 trillion of assets under management is benchmarked to major Russell indexes, which are set to be rebalanced after the stock market’s close on June 23, according to a Goldman Sachs Group research report published Monday evening.

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
What Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 18 May 2023

Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

(Bloomberg) -- European biotech firm Argenx SE is scheduled to release key drug trial data this s...

Bloomberg via Yahoo Finance 17 May 2023

Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears

Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc's...

Reuters via Yahoo News 17 May 2023

U.S. stocks will soon be reshuffled in the Russell reconstitution. Here’s how Goldman Sachs sees the...

Stock-market investors are soon facing a reconstitution of U.S. Russell indexes, an annual proces...

Market Watch 16 May 2023

FTC sues to block Amgen’s acquisition of Horizon Therapeutics

The Federal Trade Commission is suing to block biopharma giant Amgen Inc.’s proposed acquisition ...

Market Watch 16 May 2023

U.S. antitrust enforcers are chilling big mergers

The U.S. government’s aggressive stance on antitrust is chilling merger activity among the countr...

The Columbian 15 May 2023

Prometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?

Momentum investing revolves around the idea of following a stock's recent trend in either directi...

Zacks via Yahoo Finance 12 May 2023

Top Small-Cap Stocks for May 2023

Biggest movers include Prometheus, Arcellx, and Madrigal, all more than quadrupling in price in t...

Investopedia 11 May 2023

US Antitrust Enforcers Are Chilling Big Mergers

(Bloomberg) -- The US government’s aggressive stance on antitrust is chilling merger activity amo...

Bloomberg via Yahoo News 10 May 2023

With 67% ownership, Prometheus Biosciences, Inc. (NASDAQ:RXDX) boasts of strong institutional...

Key Insights Institutions' substantial holdings in Prometheus Biosciences implies that they have ...

Simply Wall St. via Yahoo Finance 29 Apr 2023